Skip to main content
Premium Trial:

Request an Annual Quote

Sophia Genetics Providing NHS, Turkish Lab Access to Bioinformatics Platform

NEW YORK (GenomeWeb) – Bioinformatics firm Sophia Genetics today announced deals with the UK's National Health Service and an unnamed Turkish laboratory to provide them access to the company's data-driven medicine platform.

The platform offers a secure software-as-a-service module for the analysis, validation, quality control, and presentation of genetic tests to clinicians, as well as storage and data sharing capabilities.

Lausanne, Switzerland-based Sophia said that it has developed algorithms based on machine learning and iterative Bayesian mathematics for an unbiased view of the data.

"As next-generation sequencing becomes more common, we are seeing more oncologists and clinicians demand the degree of accuracy and readability that Sophia Genetics offers, and we take pride in the fact that we provide them with unique reports they can act on immediately," Sophia CEO Jurgi Camblong said in a statement.

Last week, the company announced it obtained the CE-IVD mark for its next-generation sequencing bioinformatics pipeline for routine genetic testing. Earlier in the summer it said that it raised $13.75 million in a Series B financing round.

The Scan

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.

SpliceVault Portal Provides Look at RNA Splicing Changes Linked to Genetic Variants

The portal, described in Nature Genetics, houses variant-related messenger RNA splicing insights drawn from RNA sequencing data in nearly 335,700 samples — a set known as the 300K-RNA resource.

Automated Sequencing Pipeline Appears to Allow Rapid SARS-CoV-2 Lineage Detection in Nevada Study

Researchers in the Journal of Molecular Diagnostics describe and assess a Clear Labs Dx automated workflow, sequencing, and bioinformatic analysis method for quickly identifying SARS-CoV-2 lineages.

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.